207 related articles for article (PubMed ID: 36293142)
1. Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer.
Marcelo GA; Galhano J; Robalo TT; Cruz MM; Marcos MD; Martínez-Máñez R; Duarte MP; Capelo-Martínez JL; Lodeiro C; Oliveira E
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293142
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin@Doxorubicin-Epirubicin functionalized MCM-41 mesoporous silica-based nanocarriers as synergistic drug delivery tools for cancer related bacterial infections.
Galhano J; Marcelo GA; Duarte MP; Oliveira E
Bioorg Chem; 2022 Jan; 118():105470. PubMed ID: 34814085
[TBL] [Abstract][Full Text] [Related]
3. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
Tran VA; Vo VG; Shim K; Lee SW; An SSA
Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
[TBL] [Abstract][Full Text] [Related]
4. A dual catalytic functionalized hollow mesoporous silica-based nanocarrier coated with bacteria-derived exopolysaccharides for targeted delivery of irinotecan to colorectal cancer cells.
Fatemi M; Meshkini A; Matin MM
Int J Biol Macromol; 2024 Feb; 259(Pt 1):129179. PubMed ID: 38181911
[TBL] [Abstract][Full Text] [Related]
5. Magnetic targeting and pH-microwave dual responsive Janus mesoporous silica nanoparticles for drug encapsulation and delivery.
He Y; Wang C; Wu Q; Zhang G
Nanotechnology; 2024 May; 35(31):. PubMed ID: 38657569
[TBL] [Abstract][Full Text] [Related]
6. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system.
Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M
Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835
[TBL] [Abstract][Full Text] [Related]
7. Egg-yolk core-shell mesoporous silica nanoparticles for high doxorubicin loading and delivery to prostate cancer cells.
Tiburcius S; Krishnan K; Jose L; Patel V; Ghosh A; Sathish CI; Weidenhofer J; Yang JH; Verrills NM; Karakoti A; Vinu A
Nanoscale; 2022 May; 14(18):6830-6845. PubMed ID: 35441642
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive Mesoporous Silica Particles as Versatile Carriers for Doxorubicin Delivery in Cancer Therapy.
Zaltariov MF; Ciubotaru BI; Ghilan A; Peptanariu D; Ignat M; Iacob M; Vornicu N; Cazacu M
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834134
[TBL] [Abstract][Full Text] [Related]
9. Dual-Therapeutics-Loaded Mesoporous Silica Nanoparticles Applied for Breast Tumor Therapy.
Li X; He G; Jin H; Tao J; Li X; Zhai C; Luo Y; Liu X
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46497-46503. PubMed ID: 31738505
[TBL] [Abstract][Full Text] [Related]
10. Drug delivery and anticancer activity of biosynthesised mesoporous Fe
Abolhasani Zadeh F; Abdalkareem Jasim S; Atakhanova NE; Majdi HS; Abed Jawad M; Khudair Hasan M; Borhani F; Khatami M
IET Nanobiotechnol; 2022 May; 16(3):85-91. PubMed ID: 35293680
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles.
Liu J; Hu X; Jin S; Liang XJ; Ma X
J Mater Chem B; 2022 Jan; 10(3):384-395. PubMed ID: 34935843
[TBL] [Abstract][Full Text] [Related]
12. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of biodegradable Mn-doped mesoporous silica nanoparticles for pH/redox dual response drug delivery.
Li X; Zhang X; Zhao Y; Sun L
J Inorg Biochem; 2020 Jan; 202():110887. PubMed ID: 31670257
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.
Porrang S; Rahemi N; Davaran S; Mahdavi M; Hassanzadeh B
Eur J Pharm Sci; 2021 Aug; 163():105866. PubMed ID: 33957220
[TBL] [Abstract][Full Text] [Related]
15. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
17. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
18. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
[TBL] [Abstract][Full Text] [Related]
19. A self-targeting and controllable drug delivery system constituting mesoporous silica nanoparticles fabricated with a multi-stimuli responsive chitosan-based thin film layer.
Chen C; Yao W; Sun W; Guo T; Lv H; Wang X; Ying H; Wang Y; Wang P
Int J Biol Macromol; 2019 Feb; 122():1090-1099. PubMed ID: 30219514
[TBL] [Abstract][Full Text] [Related]
20. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy.
Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L
Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]